TABLE 5.
System for ranking recommendations in clinical guidelines recommended by IDSAa
| Category, grade | Definition |
|---|---|
| Strength of recommendation | |
| A | Good evidence to support a recommendation for use |
| B | Moderate evidence to support a recommendation for use |
| C | Poor evidence to support a recommendation for use |
| D | Moderate evidence to support a recommendation against use |
| E | Good evidence to support a recommendation against use |
| Quality of evidence | |
| I | Evidence from one or more properly randomized, controlled trials |
| II | Evidence from one or more well-designed clinical trials, without randomization; from cohort or case-controlled analytic studies (preferably from more than one center); from multiple time series; or from dramatic results from uncontrolled experiments |
| III | Evidence from opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees |
Reprinted from reference 51 with permission.